Quince Therapeutics, Inc. - 8-K Filing
Quince Therapeutics filed to announce it will implement a reverse stock split at a ratio of 1-for-20 effective June 29, 2026. The company had previously received shareholder approval for the split range (1-for-10 to 1-for-100) in its June 11 annual meeting. Shares will trade on a split-adjusted basis under symbol QNCX starting June 30. (Items: 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year The information set forth in Item 3, 9.01 Financial Statements and Exhibits)
Tickers: $QNCX